chrisvoncsefalvay/vaers-outcomes huggingface dataset:
red spot on the left arm; feverish spot on the left arm; red spot on the left arm; feverish spot on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of RASH MACULAR (red spot on the left arm), the second episode of RASH MACULAR (red spot on the left arm), the first episode of PYREXIA (feverish spot on the left arm) and the second episode of PYREXIA (feverish spot on the left arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced the first episode of RASH MACULAR (red spot on the left arm) and the first episode of PYREXIA (feverish spot on the left arm). On 14-Apr-2021, the patient experienced the second episode of RASH MACULAR (red spot on the left arm) and the second episode of PYREXIA (feverish spot on the left arm). At the time of the report, last episode of RASH MACULAR (red spot on the left arm) and the last episode of PYREXIA (feverish spot on the left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not provided. Concomitant medication not provided.
Redness, itching at injection site appeared 6 days after injection was received. Upon injection through today, soreness at injection spot. Chills, body aches, fatigue, headaches
Sore arm, radiating over 48 hours to underside of arm, armpit and breast; fever over 101 degrees; chills; headache; body aches: mild nausea; gas; insomnia
Pt recvd 3 doses of vax & 4 hrs later pt fainted; pt is also non-responder to vax series;
Patient explained that a few hours after the shot she started experiencing severe pain in her arm that made her go to the emergency room.
16OCT 130 shivering; 530 temp 104.4 - gave APAP; 1015 sz activity, eyes back, arms shaking, lifeless look; ER APAP suppository, bath x 2; 19OCT MD dx: ear inf; rx: amoxicillin x 10 days;
Approximately 20 hours after vaccination, my mom's arm began to swell and turn bright red. Approximately 48 hours after vaccination, it had swollen to about twice the normal size. Around the vaccination site was a bright red, somewhat raised circle approximately 8" in diameter. It was extremely itchy. This lasted for about 5 days before beginning to subside into what looks like a huge round bruise. There was also significant muscle pain in the arm. The rash is still visible now, one week after vaccination, but the itching has subsided. I have a photo if needed.  My mom had a similar but less pronounced reaction after her first dose on 2/14/2021. The symptoms lasted about 2 weeks before subsiding completely.
It started out as extreme arm pain which turned into shoulder pain that still hasn't gone away. I can barely lift my arm some days and it just isn't getting better. The pain got so constant it made it impossible to sleep which has caused me to start having a round of panic attacks.
being exposed to someone who is positive for covid; head cold; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient stated, "calls to ask if she is able to get the second dose of the vaccine after being exposed to someone who is positive for covid. Caller reports that she received the first dose of the vaccine on 18Dec and is scheduled to get her second dose on 08Jan.  Since her first dose her son and husband have been found positive for covid and she was tested today, no result back yet. She requests information about vaccination following exposure reporting that when she asked her work place they said they didn't have any information about it. Caller also reports that she is experiencing a "head cold" this week but states "it's not from the vaccine".  The outcome of the events were unknown.   Information on the lot number has been requested.
This is to report my reaction to the Covid19 vaccination. Yesterday, January 26, 2021, I took the Covid19 vaccination at 2:50 pm. Around 10:00 pm I started to feel soreness running up my arm to my shoulder and down to my forearm from the injection site. All night, the pain kept getting worse. By 3:00 am the pain reached a level 8 with any movement jumping to an intolerable level 10, the worst pain I've ever experienced from any vaccination I've ever have taken. Needless to say, I was in pain all night. I have no other symptoms at this time. Should I be concerned?
blistering rash on hands; pimples with extreme swelling; itching; burning near the knuckles; fingers became swollen; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), HEADACHE (headache), BLISTER (blistering rash on hands), DERMATITIS ACNEIFORM (pimples with extreme swelling) and PRURITUS (itching) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced FATIGUE (fatigue) and HEADACHE (headache). On 03-Apr-2021, the patient experienced BLISTER (blistering rash on hands), DERMATITIS ACNEIFORM (pimples with extreme swelling), PRURITUS (itching), BURNING SENSATION (burning near the knuckles) and PERIPHERAL SWELLING (fingers became swollen). The patient was treated with TRIAMCINOLONE at a dose of 1 dosage form and PREDNISONE at a dose of 1 dosage form. At the time of the report, FATIGUE (fatigue), HEADACHE (headache), BLISTER (blistering rash on hands), DERMATITIS ACNEIFORM (pimples with extreme swelling), PRURITUS (itching), BURNING SENSATION (burning near the knuckles) and PERIPHERAL SWELLING (fingers became swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medicine was reported by the reporter.   This case was linked to MOD-2021-148374.
Slight headache, slight chills, exhaustion (about 18 hours after injection); Itchy and inflamed, red rash/hard bump under skin around area of injection. (About 36 hours after)
DEVELOPED CHILLS, BODY ACHES, AND FATIGUE. LASTED APPROXIMATELY 24 HOURS BEFORE RESOLVING.
Patient's sister called about 4 hours after patient left our facility after receiving the high dose flu vaccine. Patient was experiencing fever, myalgias and confusion. Patient was advised to go to ER for evaluation.
shortness of breathe, cough, wheezing, headache, tachycardia, fever, rib pain, possible pneumonia
the patient received an improperly stored dose of PNEUMOVAX 23; This spontaneous report has been received from a pharmacist concerning a patient of unknown age and gender. The patient's medical history, drug allergies, concurrent conditions and concomitant therapies were not reported.  On 08-SEP-2020, the patient received an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) with lot number T010779, expiration date on 30-JAN-2022, for prophylaxis (dose, dose number, route of administration and anatomical location were not provided).  It was reported that the vaccine was exposed to a temperature of 70 Fahrenheit degrees for 5 hours. There was no previous temperature excursion. The call was not placed because of a Digital Data logger report. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T010779; expirationdate: 30-JAN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Fever,  headache,  rash at injection site, muscle pain, red patch on upper lip 24hrs later
Itching of tongue, mouth, throat; Itching of tongue, mouth, throat; Itching of tongue, mouth, throat; lump in throat; 2 asthma flare-ups; face swollen; itching on face, head and around eyes; itching on face, head and around eyes; Occasional waves of feeling very warm; burning feeling around elbows; This is a spontaneous report from a contactable consumer reporting for herself. A 62-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine administered via an unspecified route in left arm, on 07Mar2021 13:30, at 62 years of age, (Batch/Lot Number: EN6205) as single dose for COVID-19 immunization. Medical history included contrast media allergy, asthma, hypertension, hypothyroidism, glucose tolerance impaired (pre-diabetic) and allergy to erythromycin, cefaclor (CECLOR), penicillin, cefalexin (KEFLEX), neosporine, polysporin, sulfa drugs, eggs, tree nuts, peanuts, fish, shellfish, mushrooms, mustard, chocolate, some melons, raw apples (rashes of hives reactions). The patient didn't receive any other vaccine in the four weeks previous to COVID-19 vaccine. The patient received unspecified concomitant medications. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested from COVID-19 post vaccination. On 07Mar2021 at 13:45 the patient experienced itching of tongue, mouth and throat, sometimes lump in throat, 2 asthma flare-ups, face swollen, itching on face, head and around eyes, occasional waves of feeling very warm and burning feeling around elbows. The patient began treatment with famotidine (PEPCID) and diphenydramine hydrochloride (BENADRYL), contacted Doctor's office, then went to ER the day before this report. The physician assistant in ER prescribed 20 mg prednisone daily for 5 days. At the time of the report the reported events had not resolved yet.  No follow-up attempts are possible. No further information is expected.
the vial was initially stored in the refrigerator: 12JAN2023, (BUD: 11-FEB-2023); No adverse event; 1 dose was administered after the 30 day BUD yesterday, 13FEB2023.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1 dose was administered after the 30 day BUD yesterday, 13FEB2023.), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator: 12JAN2023, (BUD: 11-FEB-2023)) and NO ADVERSE EVENT (No adverse event) in an 85-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 014H22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 13-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (1 dose was administered after the 30 day BUD yesterday, 13FEB2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator: 12JAN2023, (BUD: 11-FEB-2023)) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (1 dose was administered after the 30 day BUD yesterday, 13FEB2023.), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator: 12JAN2023, (BUD: 11-FEB-2023)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (1 dose was administered after the 30 day BUD yesterday, 13FEB2023.) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator: 12JAN2023, (BUD: 11-FEB-2023)).    No concomitant medications were reported. It was reported that patient had received Moderna COVID-19 bivalent boosters that are 3 days beyond the 30 day use by date 11-Feb-2023. Patient was not reported any adverse reactions at this time. Individual vials or intact cartons: Unknown.  Vial size? 0.4 mL, 2.5 mL or 5.5 mL: 5 ml. Vial was not undergone to any temperature excursions. No treatment medications were reported.
Site irritation redness, swelling, soreness, fever, hoarseness, closing of throat, severe chills, headache.
3 days after vaccine, developed bumps and rash on left side of neck. By 6 days had turned to blisters and rash, and was confirmed by dermatologist on 9/19 that I had developed shingles. Started Valtrax that night. On 9/26 noticed another line of red bumps on the other side of neck, almost exact same area as left side rash, and seem to be getting worse.
localized redness to right upper thigh mom noticed it for the first time today administration was 2 days ago
Mom says child woke up with crusty nose, headache, diarrhea. Also no heat at home. Mom called school to say she kept child home today.
Reporting administration error as per immunization system. WE contacted Pfizer for expiration dates, Pfizer vaccine specialist advised expiration dates and deemed vaccine viable at the time of vaccine administration. Pfizer vaccine vials only include manufacturer dates on the box and vials. Therefore, we contacted Pfizer to attain expiration dates directly from them.  No adverse reaction reported from the patietn at the time of the vaccination and no adverse reaction reported since given vaccine.
Headache for three weeks and still present. Stronger headache the first week but still difficult to use the computer for more than a few minutes.
Chest pain with elevated ESR/CRP. Elevated temperature and tachycardia with hypertension. Questionable pericarditis/myocarditis that lasted 48-72 hours. Subsequently developed type 3-4 delayed hypersensitivity rash on torso and buttocks.
got Covid; past 42 days to receive the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (got Covid) and PRODUCT DOSE OMISSION ISSUE (past 42 days to receive the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (got Covid) and PRODUCT DOSE OMISSION ISSUE (past 42 days to receive the second dose). At the time of the report, SARS-COV-2 TEST POSITIVE (got Covid) and PRODUCT DOSE OMISSION ISSUE (past 42 days to receive the second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive (Positive) positive.         Concomitant medications were not provided. Treatment information was not reported.   Reporter did not allow further contact
Patient received the Pfizer COVID-19 Vac-TriS 5-11y vaccine instead of the Pfizer SARS-COV-2 COVID-19 Vaccine for adults.  This was her booster dose.  She received a 0.3mL dose.  No adverse events noted.  She is being re-scheduled to have the adult dose administered.
Pt. states she experienced right arm soreness right after receiving the vaccine. Pain worsened and spread down her arm. Tuesday (3/22/22) patient was seen in office for arm pain, no rash noted at that time. That evening she began with a bruise-like rash around the injection site. It has since spread and pain has worsened. Patient also describes paresthesias when using hand. Patient evaluated in office 3/24/22 for arm pain and rash - purpuric rash seen, sent to emergency department.
Pt had a negative response to the Pfizer injection. This was her 2nd dose. When doing the Covid injection screening in her chart, she did mention that she had some itchiness and a rash after the first injection. I had FNP assess her and clear her to have the injection. Pt was cleared and vaccination was given. Pt stated she didnt even feel the injection and looked well. I told her to wait the allotted 15 mins and left the door open. I told her that if she felt anything coming on, to say something,  as we had staff in ear shot. Pt understood. By the time I was finished giving the next 2 injections to the next 2 Pt's on the schedule, 2 staff members were holding and supporting Pt because she was not able to hold herself up. Pt was no responsive in the physical sense but when I asked her if she was scared, she started to cry. Which  indicated to us that she could hear us and understood. BS was low at 79. Juice was given. She was able to take small sips when strongly encouraged.  BP was 148/78 at one point but eventually leveled out. Pulse was around 120 but then lowered. We had tried to cool her down with a cool pack, as she was sweating. Temp was  normal at 98.2 degrees. AED was obtained and  911 was called. I told Pt that I had called her emergency contact/Husband of what had happened and to meet her at  Hospital. Her husband didnt sounds distressed on the phone. Pt was taken by ambulance with all of her belongings. the Supervisor was informed of the situation and agreed to call Pt on Monday to do a wellness phone check.
Fever (102) , chills, muscle aches, extremely sore arm, rash at injection site, nausea
all sort of joint problems; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ARTHROPATHY (all sort of joint problems) in a 5-decade-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHROPATHY (all sort of joint problems). At the time of the report, ARTHROPATHY (all sort of joint problems) outcome was unknown.            Concomitant medications were not reported.  Patient in 40s. Treatment medications were not reported.
I started to feel dizzy, when I was sitting in the car first 15 minutes; This is a spontaneous report received from contactable consumer (patient). A 60-year-old female Patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported) via unspecified route of administration on 08Apr2021 as single dose for Covid-19 immunisation. Medical history and concomitant medication were not reported. Patient started to feel dizzy, when patient was sitting in the car first 15 minutes on an unspecified date in 2021, my husband said, maybe you are worked up. I did not think much of it. I have been having Dizziness off and on since then. patient not sure patient wants to take the second dose is there a recommendation? The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a consumer (a patient's mother) refers to her female child of unknown age. The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with M-M-R II (lot #, expiration date, dose and route of administration were not provided). The patient was 15-18 months old when was vaccinated. On an unknown date, after getting the vaccine, the patient became intolerant to avocado and would projectile vomit it whenever she ate it. The outcome of food (avocado) intolerance was reported as recovered on an unknown date . The relatedness between the event and vaccination with M-M-R II was not defined by reporter.
SOB & wheezing rt p/inject; aching in joints that lasted 1-2 days; No fever, no swelling; Used Provental inhale x 1; Resolved as of 22JUN93;
Patient received the flu vaccine on 10/18/22.  It was reported that he passed away 10/21/22 when he did not wake up from his nap.
Injection site became swollen, red, and warm a week (1/28)  after vaccination. Headaches have been occurring since 1/26.
About 2 to 4 weeks, some persistent shoulder pain started, and kept steady for the following months. It was bothersome especially when trying to sleep on the should, but occasionally also some movements. After taking a third dose in mid November 2021 (Moderna), and after the acute pain of the shot passed (3 days), the previous persistent pain became a lot worse, and now hurts with almost every movement and seems to be getting worse every week. I will soon do more tests.
Reported in System - Pfizer diluted with Sterile Water instead of sodium chloride.
pt had a positive COVID test on 9/14/2021; requested med records; the wrong pt's records were sent; refaxed for records and they were not received by this time; per death certificate, a positive COVID test was listed as a contributing factor; death certificate sent per VAERS request
This spontaneous report as received from a physician refers to 1 year old patient of unknown gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 20-JAN-2016, the patient was vaccinated with VARIVAX (lot # L049536 expiry date 06-DEC-2017, dosage information not provided). Concomitant medication was not provided. On an unknown date in 2016, the patient experienced local cellulitis. On 06-MAY-2016, the patient was seen by the physician and the patient was treated with KEFLEX for local cellulitis. Since then patient's symptoms were resolved, on an unknown date. Causality assessment was not provided. Upon internal review "cellulitis" was determined to be medically significant. This is one of several cases received from the same source. Additional information has been requested.
mild arm soreness for a day or two; low fever; fatigue; This is a spontaneous report from contactable Physician (patient) via Pfizer Sales Representative. A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. He received the first dose on an unknown date for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received the Pfizer COVID vaccine, had mild arm soreness for a day or two after both injections. After the second injection he felt low fever, fatigue for 2 days. He feels fine now. Events outcome was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt received Dapt & IPV in left upper arm on 6/13 on 6/15 the left deltoid area with received Dapt had a large erythematous swollen area which was warm and tender to touch. area 5 X 5cm.  pt started on keflex and compresses.